Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease – Novartis

After years of plentiful employment opportunities, healthy pay bumps and pandemic savings-fueled spending sprees, American workers now face a sobering…

The major averages started the new week with solid gains on Monday. #stockmarket #breaking

Here’s what could be next for Intel stock. #stockmarket #breaking